These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0). Sakuragi N, Yamada H, Oikawa M, Okuyama K, Fujino T, Sagawa T, Fujimoto S. Gynecol Oncol; 2000 Nov; 79(2):251-5. PubMed ID: 11063653 [Abstract] [Full Text] [Related]
3. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer. Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N. Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407 [Abstract] [Full Text] [Related]
4. Prognostic significance of systematic lymphadenectomy as part of primary debulking surgery in patients with advanced ovarian cancer. Chang SJ, Bristow RE, Ryu HS. Gynecol Oncol; 2012 Sep; 126(3):381-6. PubMed ID: 22609747 [Abstract] [Full Text] [Related]
5. Lymph node-positive stage IIIC ovarian cancer: a separate entity? Berek JS. Int J Gynecol Cancer; 2009 Dec; 19 Suppl 2():S18-20. PubMed ID: 19955908 [Abstract] [Full Text] [Related]
6. Does systematic lymphadenectomy have a benefit on survival of suboptimally debulked patients with stage III ovarian carcinoma? A DEGOG* Study. Saygili U, Guclu S, Uslu T, Erten O, Ture S, Demir N. J Surg Oncol; 2002 Nov; 81(3):132-7. PubMed ID: 12407725 [Abstract] [Full Text] [Related]
7. Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors. Culine S, Theodore C, Farhat F, Bekradda M, Terrier-Lacombe MJ, Droz JP. J Surg Oncol; 1996 Mar; 61(3):195-8. PubMed ID: 8637206 [Abstract] [Full Text] [Related]
8. Evaluation of cytoreductive surgery with pelvic and paraaortic lymphadenectomy and intermittent cisplatin-based combination chemotherapy for improvement of long-term survival in ovarian cancer. Yokoyama Y, Sakamoto T, Sato S, Saito Y. Eur J Gynaecol Oncol; 1999 Mar; 20(5-6):361-6. PubMed ID: 10609495 [Abstract] [Full Text] [Related]
9. Long-term results in patients with advanced epithelial ovarian carcinoma treated with a combination of cisplatin, doxorubicin, and cyclophosphamide. Colozza M, Mosconi AM, Gori S, Belsanti V, Basurto C, De Angelis V, Giansanti M, Tonato M. Am J Clin Oncol; 1997 Oct; 20(5):522-6. PubMed ID: 9345342 [Abstract] [Full Text] [Related]
10. Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer? Bizzarri N, du Bois A, Fruscio R, De Felice F, De Iaco P, Casarin J, Vizza E, Chiantera V, Corrado G, Cianci S, Magni S, Ferrari D, Giuliani D, Harter P, Ataseven B, Bommert M, Perrone AM, Scambia G, Fagotti A. Gynecol Oncol; 2021 Jan; 160(1):56-63. PubMed ID: 33168305 [Abstract] [Full Text] [Related]
11. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma. Hiura M, Nogawa T, Matsumoto T, Yokoyama T, Shiroyama Y, Wroblewski J. Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408 [Abstract] [Full Text] [Related]
12. The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after tumor downstaging with induction chemotherapy. Vlastos G, Mirza NQ, Lenert JT, Hunt KK, Ames FC, Feig BW, Ross MI, Buzdar AU, Singletary SE. Cancer; 2000 Mar 15; 88(6):1417-24. PubMed ID: 10717625 [Abstract] [Full Text] [Related]
13. Evaluation of complete surgical staging with pelvic and para-aortic lymphadenectomy and paclitaxel plus carboplatin chemotherapy for improvement of survival in stage I ovarian clear cell carcinoma. Ho CM, Chien TY, Shih BY, Huang SH. Gynecol Oncol; 2003 Mar 15; 88(3):394-9. PubMed ID: 12648592 [Abstract] [Full Text] [Related]
14. Lymph node metastasis in stage I epithelial ovarian cancer. Suzuki M, Ohwada M, Yamada T, Kohno T, Sekiguchi I, Sato I. Gynecol Oncol; 2000 Nov 15; 79(2):305-8. PubMed ID: 11063662 [Abstract] [Full Text] [Related]
15. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network. Gasimli K, Braicu EI, Nassir M, Richter R, Babayeva A, Chekerov R, Darb-Esfahani S, Sehouli J, Muallem MZ. Ann Surg Oncol; 2016 Apr 15; 23(4):1279-86. PubMed ID: 26832880 [Abstract] [Full Text] [Related]
16. [The surgical treatment of ovarian cancer]. Burghardt E, Lahousen M, Stettner H. Geburtshilfe Frauenheilkd; 1990 Sep 15; 50(9):670-7. PubMed ID: 2272432 [Abstract] [Full Text] [Related]
17. Long term results of surgery and chemotherapy in small cell lung cancer. Rea F, Callegaro D, Favaretto A, Loy M, Paccagnella A, Fantoni U, Festi G, Sartori F. Eur J Cardiothorac Surg; 1998 Oct 15; 14(4):398-402. PubMed ID: 9845145 [Abstract] [Full Text] [Related]
19. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence]. Tu H, Huang H, Huang QD, Li Z, Feng YL, Liu JH. Zhonghua Fu Chan Ke Za Zhi; 2012 Dec 15; 47(12):928-33. PubMed ID: 23324194 [Abstract] [Full Text] [Related]
20. Lymphatic spread among women with primary peritoneal carcinoma. Eltabbakh GH, Mount SL. J Surg Oncol; 2002 Nov 15; 81(3):126-31. PubMed ID: 12407724 [Abstract] [Full Text] [Related] Page: [Next] [New Search]